Investor alert: pomerantz law firm investigates claims on behalf of investors of sarepta therapeutics, inc. - srpt

New york city, ny / access newswire / may 8, 2025 / pomerantz llp is investigating claims on behalf of investors of sarepta therapeutics, inc. ("sarepta" or the "company") (nasdaq:srpt). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, ext.
SRPT Ratings Summary
SRPT Quant Ranking